Daily Intel Knowledge Base
Research pages, comparison hubs and operating guides.
A structured library for Daily Intel methodology, pricing, trust, VSL research, ad repositories, blackhat and whitehat context, niche intelligence and buyer decisions.
Indexed structure
- Core entries
- 2328+
- Collections
- 107
- Niche pages
- 626
- Glossary terms
- 57
Niche
GLP-1 Affiliate Marketing Intelligence
Daily Intel Service tracks GLP-1, semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and compounded pharmacy demand through active-scaling ads, VSLs
Niche
Nutra Niches
Directory of Daily Intel Service niche intelligence pages for GLP-1, weight loss, blood sugar, prostate, joint pain, vision, sleep, hair, dental, gut
Niche
Arthritis-Adjacent Offers: Selling to a Diagnosed Pain Buyer
Where joint comfort ends and arthritis treatment begins, and why offers in this space are written for a buyer who already knows the diagnosis.
Niche
Back and Sciatic Pain Offers: Market Map and Claim Boundaries
Enormous demand, a buyer in genuine distress, and a pain-relief promise that a supplement is not permitted to make.
Showing 160 pages
GLP-1 Affiliate Marketing Intelligence
Daily Intel Service tracks GLP-1, semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and compounded pharmacy demand through active-scaling ads, VSLs
Nutra Niches
Directory of Daily Intel Service niche intelligence pages for GLP-1, weight loss, blood sugar, prostate, joint pain, vision, sleep, hair, dental, gut
Arthritis-Adjacent Offers: Selling to a Diagnosed Pain Buyer
Where joint comfort ends and arthritis treatment begins, and why offers in this space are written for a buyer who already knows the diagnosis.
Back and Sciatic Pain Offers: Market Map and Claim Boundaries
Enormous demand, a buyer in genuine distress, and a pain-relief promise that a supplement is not permitted to make.
Bladder and Pelvic Floor Offers: Market Map and Claim Limits
An embarrassment-driven vertical with strong direct response economics and a claim ceiling set by two named conditions.
Blood Pressure Offers: Market, Buyer, and the Hypertension Line
Big demand, an easily measured outcome, and a named disease sitting directly on top of the claim the buyer wants to hear.
Bone Density Offers: Market, Buyer, and the Osteoporosis Line
A vertical with a clear buyer, an authorized health claim most operators never use, and one named disease that caps everything else.
Brain Health Offers: The Senior Market and Its Hard Compliance Ceiling
The vertical that sits closest to a named neurodegenerative disease, why that shapes every line of copy, and what operators run instead of the claim they
Candida and Yeast Offers: A Market Built on an Unofficial Diagnosis
How candida overgrowth became a mainstream nutra angle without being a recognized diagnosis, and what that means for claims.
Cholesterol Offers: The Statin-Adjacent Niche and Its Rules
Where a lipid support claim is lawful, why one popular ingredient carries drug status, and how anti-statin sentiment drives this market.
Coffee, Tea and Powder Weight Offers: Format as the Angle
Why the delivery format became the hook in weight loss, what the ritual framing buys an operator, and what still has to hold up under FTC rules.
Colon Cleanse and Regularity Offers: Market and Drug Boundaries
A vertical where several popular ingredients are regulated as over-the-counter drugs, and where the claim ceiling depends on which one is in the bottle.
Dental and Gum Offers: The Niche With No Pharma Villain
How oral health offers build a story without a drug enemy, what they can claim about gums and enamel, and why this vertical's buyer economics look unusual.
Energy and Fatigue Offers: Market Map and What Can Be Claimed
A vertical with universal demand, a diagnosis that officially does not exist, and a claim set that is easier than most operators assume.
Fertility Offers: Two Buyers, High Emotion, and a Hard Claim Ceiling
A vertical with extraordinary purchase intent, sensitive targeting rules, and almost no room to promise the outcome the buyer wants.
Gout and Uric Acid Offers: Small, Sharp, and Tightly Capped
A niche with acute, memorable pain, a measurable biomarker, and one named disease that limits everything the copy would rather say.
Gut Health and Microbiome Offers: Market Map and Rules
The vertical that swallowed bloating, energy, mood, and weight — and the specific claims that separate a probiotic ad from an IBS treatment claim.
Hair Regrowth Offers: Market, Buyer Split, and Advertising Limits
A vertical fighting two approved drugs, two very different buyers, and the single strictest set of platform rules on before-and-after imagery.
Hearing and Tinnitus Offers: What the Market Claims and What It Can
The vertical with the most institutional villain stories and one of the tightest claim ceilings — mapped from buyer to payout to platform policy.
Hemorrhoid Offers: High Urgency, High Shame, Tight Rules
A condition with an existing over-the-counter drug category, a buyer who will not talk about it, and creative that platforms will not run.
How to Choose a Nutra Niche: A Constraint-First Decision Framework
Pick the vertical your compliance tolerance, creative capability, and cash position can actually survive — not the one with the biggest payout screenshot.
Immune Support Offers: A Post-Enforcement Market, Mapped
What survived the enforcement wave that reshaped this vertical, who still buys, and which immune claims remain workable.
Inflammation Offers: The Umbrella Angle Everyone Borrows
How chronic inflammation became the connective tissue of nutra copy, what that lets an offer claim, and why the breadth is also the weakness.
Joint and Mobility Offers: Market Map and Compliance Boundaries
How joint comfort offers are positioned without naming a diagnosis, who buys them, and why this vertical stays quietly profitable while louder niches burn
Page 1 of 7